The fact that clinical signs of allergy following nasal allergen challenge were less severe in orally sensitized IKKβΔIEC mice and that this protection correlated with the levels of allergen-specific IgA in the secretions of the airways demonstrated the following two important points. The gene discussed is CD79A; the disease is allergic disease.